Moors & Cabot, Inc. Gilead Sciences, Inc. Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 23,153 shares of GILD stock, worth $2.12 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

23,153

Previous 23,345 0.82%

Holding current value

$2.12 Million

Previous $1.6 Million 21.17%

% of portfolio

0.1%

Previous 0.09%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$66.59 - $83.99 $12,785 - $16,126	-192 Reduced 0.82%	23,153 $1.94 Million
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $91,820 - $105,967	-1,454 Reduced 5.86%	23,345 $1.6 Million
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $230,487 - $281,073	3,220 Added 14.92%	24,799 $1.82 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $17,218 - $19,526	-235 Reduced 1.08%	21,579 $1.75 Million
Q3 2023 Nov 07, 2023	SELL	$73.94 - $80.67 $109,579 - $119,552	-1,482 Reduced 6.36%	21,814 $1.63 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $53,283 - $60,776	-701 Reduced 2.92%	23,296 $1.8 Million
Q1 2023 May 04, 2023	SELL	$77.31 - $88.08 $254,659 - $290,135	-3,294 Reduced 12.07%	23,997 $1.99 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $129,563 - $186,008	-2,079 Reduced 7.08%	27,291 $2.34 Million
Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $407,759 - $585,402	-6,543 Reduced 18.22%	29,370 $2.52 Million
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $152,303 - $173,969	2,558 Added 7.67%	35,913 $2.22 Million
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $7,099 - $7,996	123 Added 0.37%	33,355 $2.06 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $197,391 - $247,352	3,408 Added 11.43%	33,232 $1.98 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $164,795 - $187,045	-2,540 Reduced 7.85%	29,824 $2.17 Million
Q3 2021 Dec 08, 2021	BUY	$67.69 - $73.03 $2.19 Million - $2.36 Million	32,364 New	32,364 $2.26 Million
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $2.15 Million - $2.32 Million	-31,704 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $86,319 - $94,315	1,360 Added 4.48%	31,704 $2.18 Million
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $5,760 - $6,572	-96 Reduced 0.32%	30,344 $1.96 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $95,455 - $108,766	-1,685 Reduced 5.25%	30,440 $1.77 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $119,107 - $149,757	1,918 Added 6.35%	32,125 $2.03 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $473,899 - $550,284	6,551 Added 27.69%	30,207 $2.33 Million
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $50,104 - $64,176	800 Added 3.5%	23,656 $1.76 Million
Q4 2019 Jan 28, 2020	SELL	$61.62 - $67.78 $156,638 - $172,296	-2,542 Reduced 10.01%	22,856 $1.48 Million
Q3 2019 Oct 22, 2019	BUY	$62.51 - $69.0 $260,479 - $287,523	4,167 Added 19.63%	25,398 $1.61 Million
Q2 2019 Jul 18, 2019	BUY	$61.87 - $69.38 $410,198 - $459,989	6,630 Added 45.41%	21,231 $1.44 Million
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $913,000 - $1.02 Million	-14,601 Reduced 50.0%	14,601 $954,000
Q1 2019 May 01, 2019	BUY	$62.53 - $70.05 $933,072 - $1.05 Million	14,922 Added 104.5%	29,202 $1.91 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $77,067 - $100,567	-1,273 Reduced 8.18%	14,280 $894,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $89,385 - $98,965	-1,254 Reduced 7.46%	15,553 $1.2 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $392,588 - $457,939	-6,051 Reduced 26.47%	16,807 $1.19 Million
Q1 2018 May 18, 2018	SELL	$72.84 - $88.8 $80,633 - $98,301	-1,107 Reduced 4.62%	22,858 $1.72 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $250,021 - $293,489	-3,514 Reduced 12.79%	23,965 $1.71 Million
Q3 2017 Nov 16, 2017	BUY	$72.11 - $85.47 $179,986 - $213,333	2,496 Added 9.99%	27,479 $2.22 Million
Q2 2017 Aug 15, 2017	BUY	N/A	24,983	24,983 $1.77 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account